SUBSEQUENT EVENTS (Details) - USD ($)			1 Months Ended	9 Months Ended
	Jul. 19, 2017	Apr. 07, 2016	Jul. 31, 2017	Jul. 31, 2016
Common Stock [Member]
Subsequent Event [Line Items]
Proceeds from private placement		$ 38,329
Proceeds from private placement, shares		250,000		250,000
Subsequent Event [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Proceeds from private placement			$ 38,329
Proceeds from private placement, shares			250,000
Subsequent Event [Member] | Medical technology business [Member] | Scenario, Forecast [Member]
Subsequent Event [Line Items]
Consideration owed for due diligence expenditures	$ 100,000
Consideration owed for additional due diligence expenditures	100,000
Common stock issuable as consideration for business acquisition at an issue price of USD$0.22	$ 2,500,000
Common stock issuance price per share	$ 0.22
Common stock issuable as consideration at issue price of USD$0.22 subject to the Sellers achieving sales revenue of USD$100,000 within twelve months after the first anniversary of Completion	$ 2,500,000
Common stock issuable as consideration at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$1,000,000 within twelve months after the first anniversary of Completion	$ 2,500,000
Issuance price per share for each milestone achieved	$ 0.22
Required capital to be raised by Company as part of acquisition agreement and as a condition to completion	$ 2,500,000
Subsequent Event [Member] | Medical technology business [Member] | Scenario, Forecast [Member] | Maximum [Member]
Subsequent Event [Line Items]
Purchase price	$ 7,500,000